Post-trial access to and use of pre-exposure prophylaxis in Durban, South Africa

Post-trial access to and use of pre-exposure prophylaxis in Durban, South Africa

Abstract Background HIV endpoint-driven clinical trials increasingly provide oral pre-exposure prophylaxis (PrEP) as standard of prevention during the trial, however, among participants desiring to continue using PrEP at trial exit, little is known about post-trial PrEP access and continued use. Met...

Full description

Bibliographic Details
Main Authors: Ivana Beesham, Cecilia Milford, Jenni Smit, Dvora L. Joseph Davey, Jared M. Baeten, Renee Heffron, Mags Beksinska, Leila E. Mansoor
Format: Article
Language:English
Published: BMC 2023-06-01
Series:BMC Public Health
Subjects:
Oral pre-exposure prophylaxis
Post-trial access and use
Young women
South Africa
Online Access:https://doi.org/10.1186/s12889-023-16139-z

Internet

https://doi.org/10.1186/s12889-023-16139-z

Similar Items